Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review

Cancer-associated thrombosis (CAT) is the second main cause of cancer death with high related mortality and morbidity, leading to anticancer agent delays and interruptions. The recommended therapy, low-molecular-weight heparin (LMWH), however, is burdensome for patients and costly for society, as tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fioretti, Agnese Maria, Leopizzi, Tiziana, Puzzovivo, Agata, Giotta, Francesco, Lorusso, Vito, Luzzi, Giovanni, Oliva, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325617/
https://www.ncbi.nlm.nih.gov/pubmed/35936060
http://dx.doi.org/10.1155/2022/2582923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325617/
https://www.ncbi.nlm.nih.gov/pubmed/35936060
http://dx.doi.org/10.1155/2022/2582923

Ejemplares similares